COM:BIOMARIN
BioMarin
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.biomarin.comlinkedin
biomarinfounding date
Mar 01, 1997ipo date
Jul 26, 1999
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase fo...Show More